Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.
作者信息
Rom Oren, Villacorta Luis, Zhang Jifeng, Chen Y Eugene, Aviram Michael
机构信息
Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
The Lipid Research Laboratory, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
出版信息
Curr Opin Lipidol. 2018 Oct;29(5):428-432. doi: 10.1097/MOL.0000000000000543.
Abstract
摘要
相似文献
1
Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.甘氨酸在心脏代谢疾病中的新兴治疗潜力：对脂质和葡萄糖代谢的双重益处。
Curr Opin Lipidol. 2018 Oct;29(5):428-432. doi: 10.1097/MOL.0000000000000543.
2
Targeting Apelinergic System in Cardiometabolic Disease.靶向心脏代谢疾病中的阿片肽系统。
Curr Drug Targets. 2017;18(15):1785-1791. doi: 10.2174/1389450117666160613105152.
3
New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.治疗心脏代谢疾病的新脂质和脂蛋白靶点
J Lipid Res. 2012 Sep;53(9):1719-21. doi: 10.1194/jlr.E030205. Epub 2012 Jul 5.
4
Bibliography. Current world literature. Nutrition and metabolism.参考文献。当代世界文献。营养与代谢。
Curr Opin Lipidol. 2009 Feb;20(1):63-72. doi: 10.1097/MOL.0b013e32832402a2.
5
Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.针对心脏代谢疾病的干扰素调节因子：机遇与挑战。
Curr Drug Targets. 2017;18(15):1754-1778. doi: 10.2174/1389450116666150804110412.
6
Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.环核苷酸磷酸二酯酶：内分泌、代谢及心血管功能的关键调节因子及颇具吸引力的治疗靶点。
Curr Opin Pharmacol. 2011 Dec;11(6):646-8. doi: 10.1016/j.coph.2011.10.016. Epub 2011 Nov 10.
7
Dichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic Diseases.二态性 Sirtuins：在神经退行性和心血管代谢疾病药物发现中的意义。
Trends Pharmacol Sci. 2019 Dec;40(12):1021-1039. doi: 10.1016/j.tips.2019.09.003. Epub 2019 Nov 6.
8
PPARs as targets for metabolic and cardiovascular diseases.过氧化物酶体增殖物激活受体作为代谢性疾病和心血管疾病的靶点。
Mini Rev Med Chem. 2005 Aug;5(8):741-53. doi: 10.2174/1389557054553758.
9
Osteoblastic responses to LPS, glucose-oxidised LDL and minocycline: therapeutic targets for periodontal and cardiometabolic diseases.成骨细胞对脂多糖、葡萄糖氧化低密度脂蛋白和米诺环素的反应：牙周病和心脏代谢疾病的治疗靶点
Recent Pat Endocr Metab Immune Drug Discov. 2012 Jan;6(1):73-84. doi: 10.2174/187221412799015281.
10
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.缺氧诱导因子脯氨酰4-羟化酶抑制在心脏代谢疾病中的作用
Pharmacol Res. 2016 Dec;114:265-273. doi: 10.1016/j.phrs.2016.11.003. Epub 2016 Nov 8.
引用本文的文献
1
Integrated analysis of immunometabolic interactions in Down syndrome.唐氏综合征免疫代谢相互作用的综合分析
Sci Adv. 2024 Dec 13;10(50):eadq3073. doi: 10.1126/sciadv.adq3073.
2
Effect of weight loss interventions on metabolomic signatures in obese children with insulin resistance.减肥干预对伴有胰岛素抵抗肥胖儿童代谢组学特征的影响。
Amino Acids. 2024 Aug 30;56(1):54. doi: 10.1007/s00726-024-03409-2.
3
The inverse associations of glycine and histidine in diet with hyperlipidemia and hypertension.饮食中甘氨酸和组氨酸与高血脂和高血压呈负相关。
Nutr J. 2024 Aug 22;23(1):98. doi: 10.1186/s12937-024-01005-4.
4
Advances in Understanding Cardiovascular Disease Pathogenesis through Next-Generation Technologies.通过下一代技术在理解心血管疾病发病机制方面的进展
Am J Pathol. 2024 Apr;194(4):476-481. doi: 10.1016/j.ajpath.2024.01.004.
5
Amino Acid Metabolism and Atherosclerotic Cardiovascular Disease.氨基酸代谢与动脉粥样硬化性心血管疾病。
Am J Pathol. 2024 Apr;194(4):510-524. doi: 10.1016/j.ajpath.2023.12.006. Epub 2024 Jan 1.
6
Spatially Resolved Metabolites in Stable and Unstable Human Atherosclerotic Plaques Identified by Mass Spectrometry Imaging.质谱成像技术鉴定稳定和不稳定人动脉粥样硬化斑块中的定位代谢物。
Arterioscler Thromb Vasc Biol. 2023 Sep;43(9):1626-1635. doi: 10.1161/ATVBAHA.122.318684. Epub 2023 Jun 29.
7
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease.非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病之间的相互作用。
Front Cardiovasc Med. 2023 May 2;10:1116861. doi: 10.3389/fcvm.2023.1116861. eCollection 2023.
8
Ameliorative effects of glycine on cobalt chloride-induced hepato-renal toxicity in rats.甘氨酸对氯化钴诱导的大鼠肝肾功能毒性的改善作用。
Animal Model Exp Med. 2023 Apr;6(2):168-177. doi: 10.1002/ame2.12315.
9
Phenotypic screening models for rapid diagnosis of genetic variants and discovery of personalized therapeutics.用于快速诊断遗传变异和发现个体化治疗方法的表型筛选模型。
Mol Aspects Med. 2023 Jun;91:101153. doi: 10.1016/j.mam.2022.101153. Epub 2022 Nov 18.
10
Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation.谷胱甘肽：一种具有参孙般维持生命作用的小分子，可抵御氧化应激、衰老及有害炎症。
Front Nutr. 2022 Nov 1;9:1007816. doi: 10.3389/fnut.2022.1007816. eCollection 2022.
本文引用的文献
1
Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages.脂肪细胞与巨噬细胞之间致动脉粥样硬化和促氧化的相互作用。
Eur J Nutr. 2019 Mar;58(2):879-893. doi: 10.1007/s00394-018-1729-7. Epub 2018 May 26.
2
Improved Cardiovascular Function in Old Mice After N-Acetyl Cysteine and Glycine Supplemented Diet: Inflammation and Mitochondrial Factors.补充 N-乙酰半胱氨酸和甘氨酸的饮食可改善老年小鼠的心血管功能：炎症和线粒体因素。
J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1167-1177. doi: 10.1093/gerona/gly034.
3
Branched-chain amino acids and atherosclerosis: friends or foes?支链氨基酸与动脉粥样硬化：是友还是敌？
Curr Opin Lipidol. 2018 Apr;29(2):166-169. doi: 10.1097/MOL.0000000000000494.
4
Leucine supplementation attenuates macrophage foam-cell formation: Studies in humans, mice, and cultured macrophages.亮氨酸补充可减轻巨噬细胞泡沫细胞形成：在人体、小鼠和培养的巨噬细胞中的研究。
Biofactors. 2018 May;44(3):245-262. doi: 10.1002/biof.1415. Epub 2018 Feb 5.
5
Glycine enhances expression of adiponectin and IL-10 in 3T3-L1 adipocytes without affecting adipogenesis and lipolysis.甘氨酸可增强 3T3-L1 脂肪细胞中脂联素和白细胞介素-10 的表达，而不影响脂肪生成和脂肪分解。
Amino Acids. 2018 May;50(5):629-640. doi: 10.1007/s00726-018-2537-3. Epub 2018 Jan 22.
6
Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.血清和血浆氨基酸作为糖尿病前期、胰岛素抵抗和新发糖尿病的标志物。
Crit Rev Clin Lab Sci. 2018 Jan;55(1):21-32. doi: 10.1080/10408363.2017.1414143. Epub 2017 Dec 14.
7
Insulin resistance and glycine metabolism in humans.人体胰岛素抵抗与甘氨酸代谢。
Amino Acids. 2018 Jan;50(1):11-27. doi: 10.1007/s00726-017-2508-0. Epub 2017 Nov 1.
8
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
9
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.在有和没有糖尿病的患者中，PCSK9 抑制剂依洛尤单抗的心血管安全性和疗效，以及依洛尤单抗对血糖和新发糖尿病风险的影响： FOURIER 随机对照试验的预先指定分析。
Lancet Diabetes Endocrinol. 2017 Dec;5(12):941-950. doi: 10.1016/S2213-8587(17)30313-3. Epub 2017 Sep 15.
10
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.非酒精性脂肪性肝病中氨基酸浓度的改变：肥胖和胰岛素抵抗的影响。
Hepatology. 2018 Jan;67(1):145-158. doi: 10.1002/hep.29465. Epub 2017 Nov 17.
Zotero 插件